Mark Yeoman

Dr, Ph.D Neuropharmacology, Director of the Centre for Stress and Age-related Disease

1992 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Paul R. Benjamin

  • University of Sussex
  • University of York

External person

M. Arundell

  • Imperial College London
  • University of Brighton

External person

D. O'Hare

  • Imperial College London

External person

R.N. Ranson

  • Northumbria University

External person

M.J. Saffrey

  • Open University Milton Keynes

External person

K.H. Parker

  • Imperial College London

External person

György Kemenes

  • University of Sussex
  • University of York

External person

C. J H Elliott

  • University of Sussex
  • University of York

External person

C. Wang

  • Open University Milton Keynes

External person

M. J. Brierley

  • University of Sussex
  • University of Nottingham

External person

P.P.K.M. Gamage

  • Open University Milton Keynes

External person

B. L. Brezden

  • University of Sussex
  • Carleton University

External person

Julian F. Burke

  • University of Sussex

External person

C.A. Anastassiou

  • Imperial College London

External person

Debbie Willoughby

  • University of Sussex
  • University of Cambridge

External person

Niovi Santama

  • University of Sussex

External person

M.J. Houghton

  • Open University Milton Keynes

External person

A. Vehovszky

  • University of Sussex
  • University of York

External person

Sarah Dyball

  • University of Brighton

External person

Shannon Villeneuve

  • University of Brighton

External person

Kerris Bright

  • University of Sussex

External person

L.D. Morgan

  • University of Brighton

External person

A. T. Maat

  • University of Sussex

External person

Kim Pearce

  • Brighton and Sussex Medical School

External person

L.V. Mayne

  • University of Sussex

External person

J.R. Coorssen

  • Western Sydney University

External person

Rachel Morris

  • Brighton and Sussex Medical School

External person

A. W. Pieneman

  • University of Sussex

External person

H. Baker

  • University of Brighton

External person

Andrew Rice

  • Imperial College London

External person

Tina Ghela

  • University of Brighton

External person

Chunfang Wang

  • Open University Milton Keynes

External person

K. Jin

  • University of Toronto

External person

Judy Latcham

  • GlaxoSmithKline

External person

Wildering, W.

  • University of Calgary

External person

Oliver Keattch

  • University of Brighton

External person

Alison Ritchie

  • University of Nottingham

External person

Wijnand P.M. Geraerts

  • Vrije Universiteit Amsterdam

External person

Alan Holmes

  • University College London

External person

Mfarrej, B.

  • Lebanese American University

External person

Lucy Diss

  • Brighton and Sussex Medical School

External person

Smit, A.B.

  • VU University, Amsterdam

External person

Chapman, Kathryn

  • National Centre for the Replacement, Refinement and Reduction of Animals in Research, London

External person

Colin H. Wheeler

  • Imperial College London

External person

Doug Ball

  • GlaxoSmithKline

External person

L.T. Buck

  • University of Toronto

External person

Jill Saffrey

  • Open University Milton Keynes

External person

Z.P. Feng

  • University of Toronto

External person

Lucy Dis

  • University of Brighton

External person

Potter, Paul

  • Disease Models and Translation, Mammalian Genetics Unit, MRC Harwell, Harwell, UK

External person

David R. Skingsley

  • Staffordshire University

External person

Llaria Bellatntuono

  • GlaxoSmithKline

External person

Stewart, Michelle

  • The Mary Lyon Centre, MRC Harwell, Harwell

External person

Z. Zhang

  • University of Toronto

External person

Gamage, Prasanna P.K.M.

  • General Sir John Kotelawala Defence University

External person

Andrews, Nick

  • Kirby Center for Neurobiology, Boston Children’s Hospital, Boston, US

External person

Strepka, Carol

  • Preclinical Services, Charles River, Edinburgh

External person

N. Nejatbakhsh

  • University of Toronto

External person

Rachel N. Ranson

  • Newcastle University
  • Northumbria University

External person

H.E. Collins

  • Open University Milton Keynes

External person

James Gray

  • GlaxoSmithKline

External person

Petrie, Anja

  • University of Aberdeen

External person

M. Jill Saffrey

  • Newcastle University

External person

R. Killock

  • University of Sussex

External person

Lynne Cox

  • University of Oxford

External person

R.P. Croll

  • Dalhousie University

External person

Rachel Ranson

  • Northumbria University

External person

Jackson, Samuel

  • National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK

External person

Jonathan Golding

  • University of Brighton

External person

Ka Wan Li

  • Vrije Universiteit Amsterdam

External person

Spencer, G.E.

  • Brock University

External person

Jill Saffery

  • Open University Milton Keynes

External person

V. Straub

  • University of Sussex

External person

C. Janse

  • Vrije Universiteit Amsterdam

External person

Iain Kaye

  • St John's Institute of Dermatology

External person

G. P. Ferguson

  • University of Sussex

External person

Kerris E. Bright

  • University of Sussex

External person

F. Colyer

  • Open University Milton Keynes

External person

Goldberg, J.I.

  • University of Calgary

External person

H. Davies

  • Open University Milton Keynes

External person

Syed, N.I.

  • University of Calgary

External person

Juliet Wright

  • Brighton and Sussex Medical School

External person

D. C. Parish

  • University of Sussex

External person

V.A. Straub

  • University of Toronto

External person

Gardner, D. R.

  • Carleton University

External person

Danny O'Hare

  • Imperial College London

External person